Influence of hydroxyurea on the severity of acute chest syndrome in patients with sickle cell disease

Influence of hydroxyurea on the severity of acute chest syndrome in patients with sickle cell disease

Bibliographic Details
Main Authors:	Carlos González-Pérez, Ana Gómez-Carpintero García, Áurea Cervera Bravo
Format:	Article
Language:	Spanish
Published:	Elsevier 2022-07-01
Series:	Anales de Pediatría (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S234128792200120X

Similar Items

Acute chest syndrome and COVID‐19 in hydroxyurea naïve sickle cell disease patient in a low resource setting
by: William Frank Mawalla, et al.
Published: (2022-05-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01)

Influencia de la hidroxiurea en la gravedad de los episodios de síndrome torácico agudo en pacientes con drepanocitosis
by: Carlos González-Pérez, et al.
Published: (2022-07-01)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
by: Emanuel Almeida Moreira de Oliveira, et al.

Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome
by: Joachim B. Kunz, et al.
Published: (2021-09-01)

Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation
by: Raffaella Colombatti, et al.
Published: (2011-09-01)

Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study
by: Mohammed Ali Madkhali, et al.
Published: (2024-01-01)

Hydroxyurea granules for the management of sickle cell disease in children
by: Grace Lovia Allotey-Babington, et al.
Published: (2022-07-01)

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015-03-01)

Hydroxyurea and sickle cell anemia: effect on quality of life
by: Pegelow Charles H, et al.
Published: (2006-08-01)

Methemoglobin measure in adult patients with sickle-cell anemia: influence of hydroxyurea therapy
by: Marilia Rocha Laurentino, et al.
Published: (2014-06-01)

Parafoveal acute middle maculopathy (PAMM) in sickle cell disease after discontinuation of hydroxyurea
by: Pooja Parikh, et al.
Published: (2022-12-01)

Acute chest syndrome in sickle cell disease - A review
by: Sunday Ocheni, et al.
Published: (2006-01-01)

Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia
by: Fatou Gueye Tall, et al.
Published: (2020-09-01)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
by: Luiz Bernardino Lima da Silva, et al.
Published: (2012-01-01)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
by: Ana Mach Queiroz, et al.
Published: (2021-07-01)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022-05-01)

Determining of the Hydroxyurea Effluence on TCD Parameters of Sickle Cell Patients
by: Nasser Sharafadinzadeh, et al.
Published: (2009-07-01)

Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
by: Mohammed Ali Al Sabbah, et al.
Published: (2023-07-01)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
by: Paul Lumbala Kabuyi, et al.
Published: (2023-08-01)

Cellular biophysical markers of hydroxyurea treatment in sickle cell disease
by: Du, E., et al.
Published: (2018)

Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease
by: Khayat André Salim, et al.
Published: (2004-01-01)

EVALUATION OF THE LEUKOCYTE INDEX IN SICKLE CELL ANEMIA WITH THE USE OF HYDROXYUREA
by: JO Rios, et al.
Published: (2021-10-01)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
by: Trisha E. Wong, et al.
Published: (2021-09-01)

Moderate dose of hydroxyurea in children with sickle cell disease and stroke. Preliminary results
by: Sergio Machín-García, et al.

Development of Myelodysplastic Syndrome and Acute Myeloid Leukemia 15 Years after Hydroxyurea Use in a Patient with Sickle Cell Anemia
by: Walid Baz, et al.
Published: (2012-03-01)

Development of Myelodysplastic Syndrome and Acute Myeloid Leukemia 15 Years after Hydroxyurea Use in a patient with sickle Cell Anemia
by: Walid Baz, et al.
Published: (2012-01-01)

Suspected Severe Malaria in a Sudanese Patient Affected by Sickle Cell Disease Who Was Treated with Hydroxyurea
by: Giulia Chiopris, et al.
Published: (2021-08-01)

Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome
by: Ogu UO, et al.
Published: (2021-02-01)

P-048: INFLUENCE OF SEVEN GENETIC POLYMORPHISMS ON THE RESPONSE TO SICKLE CELL DISEASE THERAPY WITH HYDROXYUREA
by: FRANCO SANTOS O., et al.
Published: (2022-08-01)

Influence of ?S-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia
by: Marília Rocha Laurentino, et al.
Published: (2014-04-01)

Hydroxyurea utilization and dose optimization in children with sickle cell disease (SCD)
by: Nour Alotaibi, et al.
Published: (2023-01-01)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease
by: Hosseini, Poorya, et al.
Published: (2018)

A systematic review on hydroxyurea therapy for sickle cell disease in India
by: Apoorva Pandey, et al.
Published: (2022-01-01)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
by: Dhiraj Kumar Yadav, et al.
Published: (2020-07-01)

Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review
by: Pagona Flevari, et al.
Published: (2022-12-01)